Emil Lou

54PUBLICATIONS
293CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Aug 31, 2026
The Molecular and Immunological Landscape in Nasopharyngeal Carcinoma (NPC) Differs by Somatostatin Receptor 2 (SSTR2) Expression.

|Jul 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset.

|Jul 10, 2026
Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer.

|Apr 08, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.

Sepideh Gholami, Anwaar Saeed, Yasmine Baca

|Jan 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpoints.

Florencia Cano, Alberto Bravo-Blas, Mathilde Colombe

|Dec 30, 2025
Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint Inhibitors.

Garima Gupta, Negar Sadeghipour, Fuat Bicer

Pageof 9

Frequent Collaborators

11 joint publications

Heinz-Josef Lenz

8 joint publications

Andrew Elliott

7 joint publications

Sanjay Goel

7 joint publications

Anthony F Shields